SCHEMBL2054847

SCHEMBL2054847

CC(=O)NCc1ccc(COc2nc(N)nc3[nH]c(CCCNC(=O)c4ccc(/N=N/c5ccc(N(C)C)cc5)cc4)nc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
MGMT P16455 1/20 0.36
HDAC1 Q13547 10/20 0.34
HDAC10 Q969S8 9/20 0.34
HDAC6 Q9UBN7 9/20 0.34
HDAC8 Q9BY41 8/20 0.34
HDAC2 Q92769 7/20 0.34
HDAC4 P56524 6/20 0.34
HDAC3 O15379 6/20 0.34
HDAC7 Q8WUI4 5/20 0.34
HDAC11 Q96DB2 5/20 0.34
HDAC9 Q9UKV0 5/20 0.34
HDAC5 Q9UQL6 5/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
MAPT P10636 2/20 0.34
PIN1 Q13526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2098271 0.92 HDAC1 (0.36) CA2HTTHDAC1HDAC10HDAC6
SCHEMBL2098275 0.92 HDAC1 (0.36) CA2HTTHDAC1HDAC10HDAC6
SCHEMBL2101048 0.92 PIN1 (0.44) CA2KDM4EALDH1A1HTTHDAC1
SCHEMBL2101045 0.92 PIN1 (0.44) CA2KDM4EALDH1A1HTTHDAC1
SCHEMBL2054846 0.83 HDAC1 (0.43) CA2KDM4EALDH1A1HTTMGMT
SCHEMBL2054840 0.80 MGMT (0.41) ALDH1A1MGMTHDAC1HDAC8HDAC2
SCHEMBL2101050 0.78 PIN1 (0.43) CA2HDAC1HDAC4PIN1
SCHEMBL2098277 0.77 NPC1 (0.31) KDM4EALDH1A1MAPT
SCHEMBL2098052 0.75 PIN1 (0.42) CA2KDM4EALDH1A1HTTHDAC1
SCHEMBL2098051 0.75 PIN1 (0.42) CA2KDM4EALDH1A1HTTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163479-B2 Specific substrates for O6-alkylguanine-DNA alkyltransferase ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2012-04-24 US disclosed
US-8163479-B2 Specific substrates for O6-alkylguanine-DNA alkyltransferase ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2012-04-24 US disclosed
US-20070243568-A1 Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2007-10-18 US disclosed
US-20070243568-A1 Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243568-A1 Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase AGT, AGXT, AGTR1 CA2 3221/4885KDM4E 3573/4885ALDH1A1 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.